Navigation Links
Asymmetrex’s Plan for Free Stem Cell Counting Is The Feature Story by Superb Crew News
Date:6/23/2020

In its June 22 online post, business and technology news platform Superb Crew reported its feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex. Superb Crew decided to highlight Asymmetrex after the company announced on June 16 that starting July 5 it would begin offering free tissue stem cell counting at its company website.

In the interview, Sherley discussed Asymmetrex’s tissue stem cell counting technology with the perspective that it is a very recent development for the industry. He noted that, like many new transformative biotechnologies, it and its value are not yet widely known. The planned free stem cell counting site is a part of Asymmetrex’s greater vision to increase academic and industry awareness of the need for tissue stem cell counting and its value, while at the same time making it readily available for immediate practice.

An earlier podcast series on “Counting Stem Cells” featured on the international stem cell industry networking platform RegMedNet, relates the many benefits of Asymmetrex’s technology for stem cell research, stem cell medicine, tissue stem cell biomanufacturing, pharmaceutical development, and environmental health science. By getting the technology out into use for free, Asymmetrex plans to “ignite a widespread adoption of tissue stem cell counting as [the] new normal” for tissue stem cell research, stem cell medicine, and drug development.

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s U.S. and U.K. patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dosage and quality of tissue stem cell preparations (the “AlphaSTEM Test™”) for use in stem cell transplantation therapies, cell biomanufacturing, and pre-clinical drug evaluations. Asymmetrex is a member company of the Advanced Regenerative Manufacturing Institute BioFabUSA and the Massachusetts Biotechnology Council.

Read the full story at https://www.prweb.com/releases/asymmetrexs_plan_for_free_stem_cell_counting_is_the_feature_story_by_superb_crew_news/prweb17210121.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Counting the invisible by sound -- a new approach to estimate seabird populations
2. Counting down to FEBS-EMBO 2014 in Paris, France
3. Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation
4. Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells
5. Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells
6. Asymmetrex Announces New Algorithms for Rapid Low Cost Counting of Therapeutic Tissue Stem Cells
7. Asymmetrex Announces Plans to Provide Free Tissue Stem Cell Counting
8. Geosphere features top geoscience technology, including LiDAR, EarthScope, CHIRP, ALSM, and IODP
9. Medbox Featured in Bloomberg Businessweek
10. Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
11. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2020)... JOSE, Calif. (PRWEB) , ... May 29, 2020 ... ... and enabler of digital transformation for enterprises globally, has collaborated with EchoNous Inc. ... the FDA. It can measure systolic heart function, which has been clinically ...
(Date:5/26/2020)... FRANCISCO (PRWEB) , ... May ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone ... of T-cell receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has ...
(Date:5/21/2020)... , ... May 20, 2020 , ... Law Enforcement has ... danger for all of us. The positions of these men and women put them ... defense for not following rules precisely. Officers have always had to face very high ...
Breaking Biology News(10 mins):
(Date:6/3/2020)... ... 03, 2020 , ... Thought Technology Ltd. is offering a ... installment, Dr. Inna Khazan will discuss the benefits of using mindfulness techniques with ... the feelings, thoughts, and emotions they are having in the present moment and ...
(Date:5/28/2020)... ... May 28, 2020 , ... Genedata, the leading ... Genedata Screener ® 17.0, the latest version of its enterprise software for ... assay technologies. Genedata will host a webinar on June 10, 2020, detailing and ...
(Date:5/21/2020)... ... May 19, 2020 , ... Experienced periodontist in Eden Prairie, MN, Dr. Andres ... grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut bone ... patient for dental implants, especially when the implants need to be placed in a ...
(Date:5/15/2020)... ... May 14, 2020 , ... Children with defective heart ... before becoming adults. The reason: there are no heart valve prosthetics designed ... the Department of Defense has awarded Draper, Boston Children’s Hospital and Seattle Children’s ...
Breaking Biology Technology: